About the Authors
- David J. Bell
-
*E-mail: belldavidj@gmail.com
Affiliations Department of Molecular and Biochemical Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom, School of Clinical Sciences, University of Liverpool, Liverpool, United Kingdom
- Suzgo K. Nyirongo
-
Affiliation Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi
- Mavuto Mukaka
-
Affiliation Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi
- Ed E. Zijlstra
-
Affiliation Department of Medicine, College of Medicine, University of Malawi, Blantyre, Malawi
- Christopher V. Plowe
-
Affiliation Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
- Malcolm E. Molyneux
-
Affiliation Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi
- Steve A. Ward
-
Affiliation Department of Molecular and Biochemical Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
- Peter A. Winstanley
-
Affiliation School of Clinical Sciences, University of Liverpool, Liverpool, United Kingdom
Competing Interests
Peter Winstanley and Steve Ward are unpaid members of the MMV-GSK product development team for chlorproguanil-dapsone-artesunate. None of the other authors declare any conflicts of interest.
Author Contributions
Conceived and designed the experiments: CP EZ MM SW DB PW. Performed the experiments: DB SN. Analyzed the data: DB MM. Contributed reagents/materials/analysis tools: CP SW MM. Wrote the paper: CP EZ MM SW DB PW.